Osteonecrosis of the jaw surgery

Osteonecrosis of the Jaw Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteonecrosis of the jaw from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging

Treatment

Medical Therapy

Surgery

Case Studies

Case #1

Osteonecrosis of the jaw surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteonecrosis of the jaw surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteonecrosis of the jaw surgery

CDC on Osteonecrosis of the jaw surgery

Osteonecrosis of the jaw surgery in the news

Blogs on Osteonecrosis of the jaw surgery

Directions to Hospitals Treating Osteonecrosis of the jaw

Risk calculators and risk factors for Osteonecrosis of the jaw surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Overview

[edit | edit source]

In cases of advanced oral ischemic osteoporosis and/or ONJ that are not bisphosphonates related, clinical evidence has shown that surgically removing the damaged marrow, usually by curettage and decortication, will eliminate the problem (and the pain) in 74% of patients with jaw involvement.[1] Repeat surgeries, usually smaller procedures than the first, may be required, and almost a third of jawbone patients will need surgery in one or more other parts of the jaws because the disease so frequently present multiple lesions, i.e. multiple sites in the same or similar bones, with normal marrow in between. In patients with bisphosphonates-associated ONJ, the response to surgical treatment is usually poor.[2] Conservative debridement of necrotic bone, pain control, infection management, use of antimicrobial oral rinses, and withdrawal of bisphosphonates are preferable to aggressive surgical measures for treating this form of ONJ.

## Surgery

[edit | edit source]

### Staging and Recommended Management[3]

[edit | edit source]

Stage | Recommended Management

|

Stage 0 | Antibiotic treatment and pain management
Stage 1 | Patient education, antibiotic mouth rinse, consider discontinuing biphosmonate therapy
Stage 2 | Debridement, oral antibiotic therapy plus antibiotic mouth rinse and pain management
Stage 3 | Debridement or resection for better infection control, oral antibiotic therapy plus antibiotic mouth rinse and pain management

## References

[edit | edit source]

1. ↑ Bouquot JE, Christian J. Long-term effects of jawbone curettage on the pain of facial neuralgia. J Oral Maxillofac Surg 1995; 53:387-397.
2. ↑ Zarychanski R, Elphee E, Walton P, Johnston J. Osteonecrosis of the jaw associated with pamidronate therapy. Am J Hematol. 2006 Jan;81(1):73-5.
3. ↑ "http://www.aaoms.org/docs/position_papers/mronj_position_paper.pdf?pdf=MRONJ-Position-Paper" (PDF). External link in `|title=` (help)